Celldex Therapeutics, Inc. (CLDX)

USD 24.82

(-4.69%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 465.62 Million 352.73 Million 444.65 Million 235.83 Million 122.93 Million 155.8 Million
Total Current Assets 431.69 Million 317.69 Million 410.83 Million 197.84 Million 66.69 Million 99.07 Million
Cash And Short Term Investments 421.69 Million 304.95 Million 408.25 Million 194.42 Million 64.38 Million 94.02 Million
Cash and Cash Equivalents 34.81 Million 29.42 Million 39.14 Million 43.83 Million 11.23 Million 24.31 Million
Short Term Investments 386.88 Million 275.52 Million 369.1 Million 150.58 Million 53.15 Million 69.71 Million
Net Receivables 4.52 Million 347 Thousand 172 Thousand 1.8 Million 1.01 Million 3.16 Million
Inventory 1.00 -347 Thousand -172 Thousand -1.8 Million -1.01 Million -3.16 Million
Other Current Assets 5.46 Million 12.74 Million 2.58 Million 3.42 Million 2.31 Million 5.05 Million
Total Non-Current Assets 33.93 Million 35.04 Million 33.81 Million 37.99 Million 56.23 Million 56.73 Million
Net PPE 6.63 Million 3.74 Million 3.55 Million 3.81 Million 4.03 Million 6.11 Million
Good Will And Intangible Assets 27.19 Million 31.29 Million 30.26 Million 34.18 Million 52.2 Million 50.61 Million
Good Will - - - - - -
Intangible Assets 27.19 Million 31.29 Million 30.26 Million 34.18 Million 52.2 Million 50.61 Million
Long-Term Investments - - - - - 1.8 Million
Tax Assets - - - - - -3.72 Million
Other Non Current Assets 107 Thousand - - - - 1.92 Million
Other Assets - - - - - -
Total Liabilities 36.45 Million 26.53 Million 25.17 Million 26.48 Million 28.9 Million 31.74 Million
Total Current Liabilities 31.12 Million 18.61 Million 16.52 Million 14.2 Million 11.64 Million 12.6 Million
Account Payables 3.49 Million 3.34 Million 1.22 Million 1.04 Million 1.17 Million 1.06 Million
Tax Payables - - - - - -
Short Term Debt 1.61 Million 1.44 Million 1.74 Million 1.32 Million 1.94 Million 4.52 Million
Deferred Revenue - - 12 Million 8.45 Million 6.49 Million 2.48 Million
Other Current Liabilities 26.01 Million 13.82 Million 1.55 Million 3.37 Million 2.02 Million 4.52 Million
Total Non Current Liabilities 5.33 Million 7.92 Million 8.65 Million 12.27 Million 17.26 Million 19.14 Million
Long-Term Debt 928 Thousand 2.58 Million 1.29 Million 2.15 Million 1.71 Million -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 4.4 Million 5.33 Million 7.35 Million 10.12 Million 15.55 Million 19.14 Million
Other Liabilities - - - - - -
Total Equity 429.17 Million 326.2 Million 419.47 Million 209.35 Million 94.02 Million 124.06 Million
Stock Holders Equity 429.17 Million 326.2 Million 419.47 Million 209.35 Million 94.02 Million 124.06 Million
Common Stock 56 Thousand 47 Thousand 47 Thousand 40 Thousand 17 Thousand 12 Thousand
Retained Earnings -1.39 Billion -1.25 Billion -1.14 Billion -1.07 Billion -1.01 Billion -962.43 Million
Accumulated other comprehensive income 3.3 Million 1.26 Million 1.89 Million 2.58 Million 2.61 Million 2.58 Million
Common Stock Equity 429.17 Million 326.2 Million 419.47 Million 209.35 Million 94.02 Million 124.06 Million
Capital Lease Obligation 928 Thousand 4.03 Million 3.04 Million 3.48 Million 3.65 Million -
Total Investments 386.88 Million 275.52 Million 369.1 Million 150.58 Million 53.15 Million 69.71 Million
Total Debt 2.54 Million 4.03 Million 3.04 Million 3.48 Million 3.65 Million 4.52 Million
Net Debt -32.27 Million -25.39 Million -36.1 Million -40.35 Million -7.57 Million -19.78 Million

Balance Sheet Charts